Jeffrey Cole
Equibles does not estimate personal net worth.
Get an email with a short summary when Cadrenal Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get CVKD alertsAbout Jeffrey Cole
Jeffrey Cole is recorded as COO at Cadrenal Therapeutics, Inc. (CVKD) since February 8, 2024. The newest filing on record that lists Jeffrey Cole as COO at Cadrenal Therapeutics, Inc. (CVKD) is dated August 3, 2026. Cadrenal Therapeutics, Inc. reported in an 8-K filed February 12, 2024 that Jeffrey Cole was appointed Chief Operating Officer, effective February 8, 2024. The proxy statement of Cadrenal Therapeutics, Inc. reports total compensation of $726,301 for Jeffrey Cole in fiscal 2024, including a base salary of $363,721. Disclosed compensation is on record for 2 fiscal years. Cadrenal Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Cadrenal Therapeutics, Inc. includes John P. Sharp (CFO), Matthew K. Szot (CFO), Quang X. Pham (CFO, Chief Accounting Officer and Board Member) and 7 others.
“On February 8, 2024, the Company issued a press release announcing the appointment of Jeffrey Cole as the Company's Chief Operating Officer.”
Affiliation history
-
Current
2024-02-08–present
Last confirmed August 3, 2026
Company network
Leadership on record at Cadrenal Therapeutics, Inc.
- John P. Sharp CFO
- Matthew K. Szot CFO
- Quang X. Pham CFO, Chief Accounting Officer, Board Member
- Class I Directors Board Member
- Glynn Wilson Board Member
- John Murphy Board Member
- Lee Golden Board Member
- Lee Scott Golden, M.D. Board Member
- Robert Lisicki Board Member
- Steven Zelenkofske Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Cadrenal Therapeutics, Inc. (CVKD) | Chief Operating Officer | $363,721 | $726,301 |
| 2023 | Cadrenal Therapeutics, Inc. (CVKD) | Chief Operating Officer | — | $24,875 |